Kintara Therapeutics Inc

-0.22 (-5.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.73M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.83 Million
Adjusted EPS-$0.58
See more estimates
10-Day MA$4.15
50-Day MA$4.12
200-Day MA$4.62
See more pivots

Kintara Therapeutics Inc Stock, NASDAQ:KTRA

9920 Pacific Heights Boulevard, Suite 150, San Diego, California 92121
United States of America
Phone: +1.858.350.4364
Number of Employees: 17


Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.